期刊文献+

甲状腺乳头状癌的生长模式与临床病理特征及整合素β4表达的相关性 被引量:4

Correlations of growth pattern of papillary thyroid carcinoma with clinicopathological features and integrin β4 expression
下载PDF
导出
摘要 目的探讨甲状腺乳头状癌(papillary thyroid carcinoma,PTC)生长模式与肿瘤临床病理特征的相关性,并分析整合素β4的表达水平与PTC生长模式间的关系。方法 59例经典型PTC依据其生长模式,分为膨胀型、局部浸润型及弥漫浸润型3组;分析其与肿瘤大小、腺外浸润、淋巴结转移及BRAFV600E突变等因素的关系;免疫组化半定量评价3组间整合素β4的表达状况。结果 (1)经典型PTC中,局部浸润型模式最常见(64%,38/59),弥漫浸润型次之(24%,14/59),膨胀型少见(12%,7/59)。(2)PTC浸润性生长模式与肿瘤腺外浸润密切相关(χ2=12.58,P<0.05)。弥漫浸润型腺外浸润的比例最高(93%,13/14),局部浸润型居中(57%,20/35),膨胀型少见(14%,1/7)。(3)整合素β4表达水平与PTC生长模式(F=20.07,P<0.05)及腺外浸润(t=2.57,P<0.05)均密切相关。β4在弥漫浸润型和局部浸润型外周区的表达高于膨胀型(P<0.05)与局部浸润型中心区(P<0.05);膨胀型与局部浸润型中心区相比,β4表达无差异(P>0.05)。(4)与3种生长模式相对应的淋巴结转移灶内的癌组织,彼此间β4的表达水平差异无显著(χ2=0.344,P>0.05)。转移性肿瘤组织β4的表达强度与膨胀型及局部浸润型中心区的水平相当,但明显低于弥漫浸润型与局部浸润型外周区的水平。结论 (1)PTC浸润性生长方式与肿瘤的高腺外浸润密切相关,特别是弥漫浸润型PTC,具有更强的腺外侵袭性。建议病理报告中列入PTC生长模式的描述,以提示其生物学行为。(2)整合素β4高表达参与/介导了PTC的间质浸润,并可能是衔接肿瘤浸润性生长模式与高侵袭生物行为间的重要分子机制。(3)PTC生长模式与肿瘤大小、临床分期、淋巴结转移及BRAFV600E突变等因素无统计学相关。 Purpose To elucidate the correlations of growth pattern in papillary thyroid carcinoma(PTC) with the clinicopathological parameters and the expression status of integrin β4.Methods 59 cases of classical PTC were subdivided into three groups: the bulking growth pattern,the focally invasive pattern and the extensively invasive pattern,based on the morphologic characteristics of stromal invasion.The relationships between growth patterns and tumor sizes,extra-thyroid invasion,lymph node metastasis as well as BRAFV600E mutation were analyzed.Furthermore,the expressional profiles of integrin β4 were detected by immunohistochemistry.Results Focally invasive PTC was of the most-commonly encountered growth pattern(64%,38/59)and subsequently followed by extensively invasive pattern(24%,14/59) and bulking pattern(12%,7/59).Invasive growth pattern was positively correlated to extra-thyroid invasion(χ2=12.58,P〈0.05) in which 93%(13/14) cases of the extensively invasive PTC and 57%(20/35) cases of the focally invasive PTC showed extra-thyroid invasion,while only 14%(1/7) cases of bulking growth related PTC manifested the same behavior.The expressional profiles of β4 statistically correlated to growth pattern of PTC(F=20.07,P〈0.05) and also to extra-thyroid invasion(t=2.57,P〈0.05).The β4 expression was obviously higher in extensively invasive pattern as well as the invasive margin of focally invasive pattern,as comparied with the bulking pattern and the central region of focally invasive pattern(P〈0.05).No differences of β4 expression were found between bulking growth pattern and the central region of focally invasive pattern(P〈0.05).In addition,β4 expression showed no differences in lymph node metastasizing foci among the three growth patterns(χ^2=0.344,P〈0.05).The intensity of β4 expression in lymph node metastasizing foci was statistically equivalent to that of bulking pattern and the central region of focally invasive pattern in the primary lesion,bu
出处 《临床与实验病理学杂志》 CAS CSCD 北大核心 2012年第10期1127-1132,共6页 Chinese Journal of Clinical and Experimental Pathology
基金 深圳市科技局立项资助(201002002)
关键词 甲状腺肿瘤 乳头状癌 整合素β4 生长模式 thyroid neoplasms papillary carcinoma integrinβ4 growth pattern
  • 相关文献

参考文献26

  • 1Bai Y,Kakudo K,Nakamura M,et al. Loss of cellular polarity/cohesiveness in the invasive front of papillary thyroid carcinomaand periostin expression[ J]. Cancer Lett, 2009 ,281 (2) : 188 -95. 被引量:1
  • 2Powell DJ Jr, Russell J, Nibu K, et al. The RET/PTC3 onco-gene :metastatic solid-type papillary carcinomas in murine thyroids[J]. Cancer Res, 1998,58(23) : 5523 -8. 被引量:1
  • 3Lin X,Finkelstein S D,Zhu B,et al. Molecular analysis of multi-focal papillary thyroid carcinoma [ J]. J Mol Endocrinol,2008,41(4) :195 -203. 被引量:1
  • 4Eloy C,Santos J,Soares P,et al. The preeminence of growth pat-tern and invasiveness and the limited influence of BRAF and RASmutations in the occurrence of papillary thyroid carcinoma lymphnode metastases[ J]? Virchows Arch,2011,459(3) :265 — 76. 被引量:1
  • 5Eloy C , Santos J, Soares P. Intratumoural lymph vessel density isrelated to presence of lymph node metastases and separates encap-sulated from infiltrative papillary thyroid carcinoma [ J ]. VirchowsArch, 2011,459(6) :595 -605. 被引量:1
  • 6Eriksen J G, Steiniche T, S0gaard H, et al. Expression of inte-grins and E-cadherin in squamous cell carcinomas of the head andneck [J]. APMIS, 2004,112(9) :560 -8. 被引量:1
  • 7Lu S, Simin K, Khan A, et al. Analysis of integrin beta4 expres-sion in human breast cancer : association with basal-like tumorsand prognostic significance [J]. Clin Cancer Res, 2008,14(4):1050 -8. 被引量:1
  • 8Beaulieu J F. Integrin a6^4 in colorectal cancer [ J]. World JGastrointest Pathophysiol, 2010,1(1) :3 -11. 被引量:1
  • 9Vasko V,Espinosa A V,Scouten W, et al. Gene expression andfunctional evidence of epithelial-to-mesenchymal transition in pa-pillary thyroid carcinoma invasion [ J]. Proc Natl Acad Sci USA,2007,104(8) :2803 -8. 被引量:1
  • 10Henderson Y C, Shellenberger T D, Williams M D, e? al. Highrate of BRAF and RET/PTC dual mutations associated with recur-rent papillary thyroid carcinoma [ J]. Clin Cancer Res, 2009 ,15(2):485 -91. 被引量:1

同被引文献70

  • 1Mai K T, Yazdi H M, Perkins D G, et al. Papillary thyroid carci- noma and related thyroid neoplastic lesions: a light microscopic study with emphasis on nuclear changes [ J ]. Tumori, 2000,86 (3) :238 -49. 被引量:1
  • 2Coli A, Bigotti G, Parente P, et al. Atypical thyroid nodules ex- press both HBME-1 and Galeetin-3, two phenotypie markers of pa- pillary thyroid carcinoma[J]. J Exp Clin Cancer Res, 2007,26 (2) : 221 -7. 被引量:1
  • 3Coli A, Bigotti G, Zucchetti F, et al. Galectin-3, a marker of well-differentiated thyroid carcinoma, is expressed in thyroid nod- ules with cytological atypia[J]. Histopathology, 2002,40( 1 ) :80 -7. 被引量:1
  • 4Mai K T, Ford J C, Yazdi H M, et al. Immunohistochemical stud- y of papillary thyroid carcinoma and possible papillary thyroid car- cinoma-related benign thyroid nodules [ J ]. Pathol Res Pract, 2000,196(8) :533 -40. 被引量:1
  • 5Fusco A, Chiappetta G, Hui P, et al. Assessment of RET/PTC oncogene activation and clonality in thyroid nodules with incom- plete morphological evidence of papillary carcinoma: a search for the early precursors of papillary cancer[ J]. Am J Pathol, 2002, 160(6) :2157 -67. 被引量:1
  • 6Gasbarri A, Sciacehitano S, Maraseo A, et al. Detection and mo- lecular characterisation of thyroid cancer precursor lesions in a spe- cific subset of Hashimoto' s thyroiditis[ J]. Br J Cancer, 2004,91 (6) :1096 -104. 被引量:1
  • 7Sheils O M, O' eary J J, Uhlmann V, et al. ret./PTC - 1 activa- tion in hashimoto thyroiditls[ J ]. Int J Surg Pathol, 2000,8 (3) : 185 -9. 被引量:1
  • 8Chiu C G, Strugnell S S, Griffith O L, et al. Diagnostic utility of Galectin-3 in thyroid cancer [ J ]. Am J Pathol, 2010,176 (5) : 2067 - 81. 被引量:1
  • 9Yoshii T, Inohara H, Takenaka Y, et al. Galectin-3 maintains the transformed phenotype of thyroid papillary carcinoma ceils[ J ]. IntJ Oncol, 2001,18(4) :787 -92. 被引量:1
  • 10Cvejic D, Savin S, Petrovie I, et al. Galeetin-3 expression in pa- pillary mieroearcinoma of the thyroid [ J ]. Histopathology, 2005, 47(2) :209 - 14. 被引量:1

引证文献4

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部